Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy

IMPORTANCE: A decision to initiate aspirin therapy for primary prevention of cardiovascular disease (CVD) requires consideration of both treatment benefits and harms. The most significant harm associated with aspirin is major bleeding, yet there is a paucity of data on bleeding risk in suitable comm...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA
Hlavní autoři: Selak, Vanessa, Kerr, Andrew, Poppe, Katrina, Wu, Billy, Harwood, Matire, Grey, Corina, Jackson, Rod, Wells, Sue
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2018
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583689/
https://ncbi.nlm.nih.gov/pubmed/29946729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.8194
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky